{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T16:27:01Z","timestamp":1715531221274},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1990,3,1]],"date-time":"1990-03-01T00:00:00Z","timestamp":636249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Wochenschr"],"published-print":{"date-parts":[[1990,3]]},"DOI":"10.1007\/bf02116055","type":"journal-article","created":{"date-parts":[[2005,9,14]],"date-time":"2005-09-14T00:56:15Z","timestamp":1126659375000},"page":"269-276","source":"Crossref","is-referenced-by-count":2,"title":["Association between sympathetic activity and the atherogenic serum cholesterol fraction"],"prefix":"10.1007","volume":"68","author":[{"given":"P.","family":"Weidmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. C.","family":"Schohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Riesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. A.","family":"Jahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. G.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Beretta-Piccoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02116055_CR1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.7326\/0003-4819-97-2-206","volume":"97","author":"K Boehringer","year":"1982","unstructured":"Boehringer K, Weidmann P, Mordasini R, Schiffl H, Bachmann C, Riesen W (1982) Menopause-dependent plasma lipoprotein alterations in diuretic-treated women. Ann Int Med 97:206\u2013209","journal-title":"Ann Int Med"},{"issue":"Suppl 1","key":"BF02116055_CR2","first-page":"123","volume":"206","author":"I Cavero","year":"1978","unstructured":"Cavero I, Gerold M, Saner A, H\u00e4usler G (1978) The cardiovascular effects of the antihypertensive drug debrisoquine: a contribution to the pharmacology of chronic treatment. J Pharmacol Exp Ther 206 [Suppl 1]:123\u2013131","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02116055_CR3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0009-8981(82)90405-3","volume":"119","author":"MK Chan","year":"1982","unstructured":"Chan MK, Ramdial L, Varghese Z, Persaud JW, Baillod RA, Moorhead JF (1982) Plasma lecithin-cholesterol acyltransferase activities in uraemic patients. Clin Chim Acta 119:65\u201372","journal-title":"Clin Chim Acta"},{"key":"BF02116055_CR4","first-page":"183","volume":"17","author":"MK Chan","year":"1982","unstructured":"Chan MK, Varghese Z, Persaud JW, Baillod RA, Moorhead JF (1982) Hyperlipidemia in patients on maintenance hemo- and peritoneal dialysis. The relative pathogenetic roles of triglyceride production and triglyceride removal. Clin Nephrol 17:183\u2013190","journal-title":"Clin Nephrol"},{"issue":"Suppl I","key":"BF02116055_CR5","first-page":"I-40","volume":"73","author":"MH Criqui","year":"1986","unstructured":"Criqui MH, Cowan LD, Heiss G, Haskell WL, Laskarzewski PM, Chambless LE (1986) Frequency and clustering of nonlipid coronary risk factors in dyslipoproteinemia. The Lipid Research Clinics Program Prevalence Study. Circulation 73 [Suppl I]:I-40\u2013I-50","journal-title":"Circulation"},{"key":"BF02116055_CR6","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/0024-3205(76)90251-4","volume":"19","author":"M Prada Da","year":"1976","unstructured":"Da Prada M, Z\u00fcrcher G (1976) Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. Life Sci 19:1161\u20131174","journal-title":"Life Sci"},{"key":"BF02116055_CR7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00004872-198504000-00003","volume":"3","author":"MD Esler","year":"1985","unstructured":"Esler MD, Hasking J, Willett JR, Leonard PW, Jennings GL (1985) Noradrenaline release and sympathetic nervous system. J Hypertens 3:117\u2013123","journal-title":"J Hypertens"},{"key":"BF02116055_CR8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0002-9343(79)90479-0","volume":"66","author":"J Flammer","year":"1979","unstructured":"Flammer J, Weidmann P, Gl\u00fcck Z, Ziegler WH, Reubi FC (1979) Cardiovascular and endocrine profile of adrenergic neurone blockade in normal and hypertensive man. Am J Med 66:34\u201342","journal-title":"Am J Med"},{"key":"BF02116055_CR9","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1210\/jcem-47-6-1173","volume":"47","author":"A Goldberg","year":"1978","unstructured":"Goldberg A, Sherrard DJ, Brunzell JD (1978) Adipose tissue lipoprotein lipase in chronic hemodialysis. Role in plasma triglyceride metabolism. J Clin Endocrinol Metab 47:1173\u20131182","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"BF02116055_CR10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/01.HYP.5.1.86","volume":"5","author":"DS Goldstein","year":"1983","unstructured":"Goldstein DS (1983) Plasma catecholamines and essential hypertension. An analytical review. Hypertension 5 [Suppl 1]:86\u201399","journal-title":"Hypertension"},{"key":"BF02116055_CR11","first-page":"646","volume":"189","author":"G H\u00e4usler","year":"1974","unstructured":"H\u00e4usler G, Lorez HP, Bartholini G, Kettler R, Tranzer JP (1974) Absence of degeneration of adrenergic neurons after prolonged treatment with debrisoquine. J Pharmacol Exp Therap 189:646\u2013658","journal-title":"J Pharmacol Exp Therap"},{"key":"BF02116055_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000181745","volume":"25","author":"CC Heuck","year":"1980","unstructured":"Heuck CC, Ritz E (1980) Hyperlipoproteinemia in renal insufficiency. Nephron 25:1\u20137","journal-title":"Nephron"},{"key":"BF02116055_CR13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000459263","volume":"25","author":"K Jung","year":"1980","unstructured":"Jung K, Neumann R, Precht K, Nugel E, Scholtz D (1980) Lecithin-cholesterol acyltransferase activity, HDL-cholesterol and apolipoprotein A in serum of patients undergoing chronic haemodialysis. Enzyme 25:273\u2013275","journal-title":"Enzyme"},{"key":"BF02116055_CR14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-90-1-85","volume":"90","author":"WB Kannel","year":"1979","unstructured":"Kannel WB, Castelli WP, Gordon T (1979) Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham Study. Ann Int Med 90:85\u201391","journal-title":"Ann Int Med"},{"issue":"Suppl 2","key":"BF02116055_CR15","first-page":"63","volume":"9","author":"L Landsberg","year":"1985","unstructured":"Landsberg L, Young JB (1985) Insulin-mediated glucose metabolism in the relationship between dietary intake and sympathetic nervous system activity. Int J Obes 9 [Suppl 2]:63\u201368","journal-title":"Int J Obes"},{"issue":"Suppl 2","key":"BF02116055_CR16","first-page":"222s","volume":"4","author":"P Leren","year":"1982","unstructured":"Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Hjeldsoen SE, Lund-Larsen PG (1982) Antihypertensive drugs and blood lipids. The Oslo Study. J Cardiovasc Pharmacol 4 [Suppl 2]:222s-224s","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF02116055_CR17","volume-title":"Manual of laboratory operations","author":"Lipid Research Clinics Program","year":"1974","unstructured":"Lipid Research Clinics Program (1974) Manual of laboratory operations. U.S. Government Printing Office, Washington, D.C."},{"issue":"Suppl 2A","key":"BF02116055_CR18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0002-9343(86)90159-2","volume":"80","author":"SW MacMahon","year":"1986","unstructured":"MacMahon SW, MacDonald GJ (1986) Antihypertensive treatment and plasma lipoprotein levels: the associations in data from a population study. Am J Med 80 [Suppl 2A]:40\u201347","journal-title":"Am J Med"},{"key":"BF02116055_CR19","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0006-2952(69)90060-4","volume":"18","author":"MA Medina","year":"1969","unstructured":"Medina MA, Giachetti A, Shore PA (1969) On the physiological disposition and possible mechanism of the antihypertensive action of debrisoquine. Biochem Pharmacol 18:891\u2013901","journal-title":"Biochem Pharmacol"},{"key":"BF02116055_CR20","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJM197712222972502","volume":"297","author":"R Mordasini","year":"1977","unstructured":"Mordasini R, Frey F, Flury W, Klose G, Greten H (1977) Selective deficiency of hepatic triglyceride lipase in uremic patients. N Engl J Med 297:1362\u20131366","journal-title":"N Engl J Med"},{"key":"BF02116055_CR21","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.1982.03330120023025","volume":"248","author":"Multiple Risk Factor Intervention Trial Research Group","year":"1982","unstructured":"Multiple Risk Factor Intervention Trial Research Group(1982) Multiple risk factor intervention trial. Risk factor changes and mortality. JAMA 248:1465\u20131477","journal-title":"JAMA"},{"key":"BF02116055_CR22","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000429303","volume":"41","author":"WF Riesen","year":"1984","unstructured":"Riesen WF, Mordasini R (1984) Hyperlipidemia in renal failure: phenotypes and pathogenetic mechanisms. Contrib Nephrol (Karger, Basel) 41:312\u2013320","journal-title":"Contrib Nephrol (Karger, Basel)"},{"key":"BF02116055_CR23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0014-5793(78)80011-8","volume":"91","author":"WF Riesen","year":"1978","unstructured":"Riesen WF, Mordasini RC, Middelhoff GW (1978) Quantitation of the two major apoproteins of human high density lipoproteins by solid phase radioimmunoassay. FEBS Lett 91:35\u201339","journal-title":"FEBS Lett"},{"issue":"Suppl 2a","key":"BF02116055_CR24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0002-9343(86)90163-4","volume":"80","author":"FM Sacks","year":"1986","unstructured":"Sacks FM, Dzau VJ (1986) Adrenergic effects on plasma lipoprotein metabolism: speculation on mechanisms of action. Am J Med 80 [Suppl 2a]:71\u201381","journal-title":"Am J Med"},{"key":"BF02116055_CR25","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0022-2275(20)38031-7","volume":"23","author":"EJ Schaefer","year":"1982","unstructured":"Schaefer EJ, Wetzel MG, Bengtsson G, Scow RO, Brewer HB Jr, Olivecrona T (1982) Transfer of human lymph chylomicron constituents to other lipoprotein density fractions during in vitro lipolysis. J Lipid Res 23:1259\u20131273","journal-title":"J Lipid Res"},{"key":"BF02116055_CR26","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/ki.1985.203","volume":"28","author":"D Schohn","year":"1985","unstructured":"Schohn D, Weidmann P, Jahn H, Beretta-Piccoli C (1985) Norepinephrine-related mechanism in hypertension accompanying renal failure. Kidney Int 28:814\u2013822","journal-title":"Kidney Int"},{"key":"BF02116055_CR27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF00563111","volume":"16","author":"JH Silas","year":"1979","unstructured":"Silas JH, Jones J, Tucker GT, Townshend MM, Phillips CA, Smith AJ (1979) Dissociation of biochemical and hypotensive effects of debrisoquine in hypertensive patients. Eur J Clin Pharmacol 16:81\u201386","journal-title":"Eur J Clin Pharmacol"},{"key":"BF02116055_CR28","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/01.HYP.4.5.686","volume":"4","author":"JR Sowers","year":"1982","unstructured":"Sowers JR, Nyby M, Stern N, Beck F, Baron S, Catania R, Vlachis N (1982) Blood pressure and hormone changes associated with weight reduction in the obese. Hypertension 4:686\u2013691","journal-title":"Hypertension"},{"key":"BF02116055_CR29","unstructured":"Technicon Clinical Methods No. 23 (1970) Technicon AAII autoanalyzer. Technicon Instruments, Tarrytown, New York"},{"key":"BF02116055_CR30","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/BF01476959","volume":"55","author":"P Weidmann","year":"1977","unstructured":"Weidmann P, de Chatel R, Schiffmann A, Bachmann E, Beretta-Piccoli C, Reubi FC, Ziegler WH, Vetter W (1977) Interrelations among age and plasma renin, aldosterone and cortisol, urinary catecholamines and the body sodium\/volume state in normal man. Klin Wochenschr 55:725\u2013733","journal-title":"Klin Wochenschr"},{"key":"BF02116055_CR31","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1210\/jcem-48-5-727","volume":"48","author":"P Weidmann","year":"1979","unstructured":"Weidmann P, Keusch G, Flammer J, Ziegler WH, Reubi FC (1979) Increased ratio between changes in blood pressure and plasma norepinephrine in essential hypertension. J Clin Endocrinol Metab 48:727\u2013731","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02116055_CR32","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1161\/01.HYP.5.6.873","volume":"5","author":"P Weidmann","year":"1983","unstructured":"Weidmann P, Beretta-Piccoli C, Link L, Bianchetti MG, Boehringer K, Morton JJ (1983) Cardiovascular counterregulation during sympathetic inhibition in normal subjects and patients with mild hypertension. Hypertension 5:873\u2013880","journal-title":"Hypertension"},{"issue":"Suppl 3","key":"BF02116055_CR33","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1097\/00005344-198800120-00019","volume":"12","author":"P Weidmann","year":"1988","unstructured":"Weidmann P, Beretta-Piccoli C (1988a) Dysregulation of blood pressure in normotensive offspring of hypertensive parents. J Cardiovas Pharmacol 12 [Suppl 3]:S134-S148","journal-title":"J Cardiovas Pharmacol"},{"issue":"Suppl 6","key":"BF02116055_CR34","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2165\/00003495-198800356-00017","volume":"35","author":"P Weidmann","year":"1988","unstructured":"Weidmann P, Ferrier C, Saxenhofer H, Uehlinger DE, Trost BN (1988b) Serum lipoproteins during treatment with antihypertensive drugs. Drugs 35 [Suppl 6]:118\u2013134","journal-title":"Drugs"},{"key":"BF02116055_CR35","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000167980","volume":"9","author":"P Weidmann","year":"1989","unstructured":"Weidmann P, Schohn D, Gn\u00e4dinger MP, B\u00fcrgisser E, Ferrier C, Jahn H (1989) Hypertensive dysregulation and its modification by calcium channel blockade in chronic non-oliguric renal failure. Am J Nephrol 9:269\u2013278","journal-title":"Am J Nephrol"}],"container-title":["Klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02116055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02116055\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02116055","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T11:48:15Z","timestamp":1626522495000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02116055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,3]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1990,3]]}},"alternative-id":["BF02116055"],"URL":"https:\/\/doi.org\/10.1007\/bf02116055","relation":{},"ISSN":["0023-2173","1432-1440"],"issn-type":[{"value":"0023-2173","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,3]]}}}